Novel and highly efficient synthesis of substituted dibenz[b,g]1,5- oxazocines. A direct comparison of the solution versus solid-phase approach

Tetrahedron

Volumn 56, Issue 16, 2000, Pages 2369-2377

  Ouyang, Xiaohu ^a   Chen, Zhidong ^a   Liu, Longbin ^a   Dominguez, Celia ^a   Kiselyov, Alexander S ^a  

^a AMGEN INC   (United States)

Author keywords

Substitution; Supported reagents reactions

Indexed keywords

CHLORPROMAZINE; DIBENZ[B,G]1,5 OXAZOCINE; FLUORIDE; IMIPRAMINE; OXAZOCINE DERIVATIVE; PHENOL; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; PRIORITY JOURNAL; REACTION ANALYSIS; REACTION TIME; SOLID STATE;

EID: 0034646776     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4020(00)00120-4     Document Type: Article

References (45)

1. (a) Mueller, A. L.; Moe, S. T. US Patent 1997, 873011.
2. (b) Vermeulin, N. M. J.; O'Day, C. L.; Webb, H. K.; Burns, M. R.; Bergstrom, D. E. US Patent 1998, 85538.
3. (c) Averback, P.; Ghanbari, H.; Beheshti, I.; Morse, D. US Patent 1997, 858343.
4. (d) Haddjeri, N.; Blier, P.; De Montigny, C. J. Neurosci. 1998, 18, 10150.
5. (e) Kuo, C. Biophys. J. 1998, 75, 2845.
6. (f) Ocharan, M. E.; Asbun, J.; Valencia, I.; Castillo, C.; Castillo, E. F. Proc. West. Pharmacol. Soc. 1998, 41, 141; Gallego, M.; Casis, L.; Casis, O. Eur. J. Pharmacol. 1998, 360, 113.
7. Gallego, M.; Casis, L.; Casis, O. Eur. J. Pharmacol. 1998, 360, 113.
8. (g) Jagadeesh, S. R.; Subhash, M. N. Biol. Psychiatry 1998, 44, 617.
9. (h) Adali, O.; Carver, G. C.; Philpot, R. M. Arch. Biochem. Biophys. 1998, 358, 92.
10. (i) Casis, O.; Sanchez-Chapula, J. A. J. Cardiovasc. Pharmacol. 1998, 32, 521.
11. (j) Zhu, J.; Mix, E.; Bengtsson, B.-O.; Link, H. J. Peripher. Nerv. Syst. 1997, 2, 30.
12. (k) Muraoka, S.; Kamei, K.; Muneoka, K.; Takigawa, M. J. Neurochem. 1998, 71, 1709.
13. (l) Boyer, P.-A.; Skolnick, P.; Fossom, L. H. J. Mol. Neurosci. 1998, 10, 219.
14. (m) Wuonola, M.; Palfreyman, M. G.; Motohashi, N.; Kawase, M.; Gabay, S.; Gupta, R. R.; Molnar, J. Anticancer Res. 1998, 18, 337.
15. (n) Pajeva, I.; Wiese, M. J. Med. Chem. 1998, 41, 1815.
16. (a) Joergensen, T. K.; Andersen, K. E.; Andersen, H. S.; Hohlweg, R.; Madsen, P.; Olsen, U. B. Dutch Patent 96-DK 138 960401; CA 1996, 713004.
17. (b) Ohgoh, T.; Tanaka, S.; Fujimoto, M.; Kitahara, A. Yakugaku Zassi 1977, 97, 24.
18. (c) Gellatly, R. P.; Ollis, W. D.; Sutherland, I. O. J. Chem. Soc., Perkin Trans. 1 1976, 913.
19. (d) Tanaka, S.; Hashimoto, K. Yakugaku Zassi 1973, 93, 1003.
20. (a) Tanaka, S.; Hashimoto, K. Japan Patent JP 690908; CA 1972, 59680.
21. (b) Tanaka, S.; Hashimoto, K.; Watanabe, H.; Sakaguchi, K. Chem. Pharm. Bull. 1973, 21, 1683.
22. (c) Tanaka, S., Hashimoto, K. US Patent 1974, 3,803,143.
23. (d) Lieb, F.; Eiter, K. Liebigs Ann. Chem. 1976, 14, 203.
24. (e) Tanaka, S.; Ogata, Y. Yakugaku Zassi 1972, 93, 1003.
25. For selected publications on SNAr see, for example: (a) Terrier, F. Nucleophilic Aromatic Displacement: The Role of the Nitro Group; VCH: New York, 1991, Chapter 1.
26. (b) Artamkina, G. A.; Egorov, M. P.; Beletskaya, I. P. Chem. Rev. 1982, 82, 427.
27. (a) Boger, D. L.; Yohannes, D.; Zhou, J.; Patane, M. A. J. Am. Chem. Soc. 1993, 115, 3420.
28. (b) Boger, D. L.; Borzilleri, R. M.; Nukui, S.; Beresis, R. T. J. Org. Chem. 1997, 62, 4721.
29. (c) Zhu, J. Syn Lett. 1997, 133 and references cited therein.
30. (d) Gonzalez, G. I.; Zhu, J. P. J. Org. Chem. 1997, 62, 7544.
31. (e) Evans, D. A.; Barrow, J. C.; Watson, P. S.; Ratz, A. M.; Dinsmore, C. J.; Evrard, D. A.; DeVries, K. M.; Ellman, J. A.; Rychnowsky, S. D.; Lacour, J. J. Am. Chem. Soc. 1997, 119, 3419.
32. (f) Evans, D. A.; Dinsmore, C. J.; Ratz, A. M.; Evrard, D. A.; Barrow, J. C. J. Am. Chem. Soc. 1997, 119, 3417.
33. (g) Kiselyov, A. S.; Eisenberg, S., Luo, Y. Tetrahedron 1998, 54, 10 635.
34. (h) Ouyang, X.; Kiselyov, A. S. Tetrahedron 1999, 55, 8295.
35. (i) Goldberg, M.; Smith, L.; Tamayo, N.; Kiselyov, A. S. Tetrahedron 1999, 55, 13 887.
36. (j) Islas-Gonzalez, G.; Zhu, J. J. Org. Chem. 1999, 64, 914.
37. Ouyang X., Tamayo N., Kiselyov A.S. Tetrahedron. 55:1999;2827.
38. (a) Beugelmans, R.; Singh, G. P.; Bois-Choussy, M.; Castanet, J.; Zhu, J. J. Org. Chem. 1994, 59, 5535.
39. (b) Zhu, J.; Beugelmans, R.; Bourdet, S.; Chastanet, J.; Roussi, G. J. Org. Chem. 1995, 60, 6389.
40. (c) Boger, D. L.; Borzilleri, R. M.; Nukui, S.; Beresis, R. T. J. Org. Chem. 1997, 4721.
41. Laib T., Zhu J. Tetrahedron Lett. 40:1999;83.
42. (a) Beugelmans, R.; Bois-Choussy, M.; Vergne, C.; Bouillon, J. P.; Zhu, J. J. Chem. Soc., Chem. Commun. 1996, 1029.
43. (b) Bois-Choussy, M.; Vergne, C.; Neuville, L.; Beugelmans, R.; Zhu, J. Tetrahedron Lett. 1997, 38, 5795.
44. Ouyang X., Armstrong R.W., Murphy M. J. Org. Chem. 63:1998;1027.
45. 2 afforded the expected amino acid in only a 7% yield. Additionally, attempts to conduct the second reductive amination reaction with 2-fluoro-5-nitrobenzaldehyde (1) were unsuccessful under a variety of experimental conditions. However, changing the reductive amination sequence proved to be beneficial.